Nurse Practitioner, Family · Temecula, CA
NPI
1679255327
Since 2023
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
31625 de Portola Rd Ste 101
Temecula, CA, 92592
Phone (951) 501-4200
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$586K
1,878 prescriptions
Company payments, 2025
$2,913
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sandra Hlavac prescribed most often to Medicare patients was Rabeprazole Sodium, with 324 prescriptions and refills. In total Sandra Hlavac wrote 1,878 Medicare prescriptions that cost $586K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rabeprazole Sodium Generic | 324 | 658 | 149 | $9,362 |
| Pantoprazole Sodium Generic | 286 | 680 | 119 | $3,170 |
| Linzess Linaclotide | 127 | 157 | 54 | $83K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 115 | 115 | 109 | $20K |
| Dicyclomine Hcl Generic | 110 | 110 | 51 | $959 |
| Ondansetron Odt Ondansetron | 73 | 73 | 44 | $980 |
| Famotidine Generic | 55 | 101 | 26 | $363 |
| Dexlansoprazole Dr Dexlansoprazole | 55 | 93 | 21 | $13K |
| Spironolactone Generic | 48 | 90 | 11 | $594 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 47 | 47 | 47 | $6,597 |
| Hydrocortisone Generic | 43 | 43 | 34 | $718 |
| Creon Lipase/Protease/Amylase | 41 | 48 | 19 | $104K |
| Trulance Plecanatide | 40 | 58 | 14 | $30K |
| Omeprazole Generic | 40 | 96 | 21 | $568 |
| Furosemide Generic | 37 | 61 | Under 11 | $81.8 |
Brand drugs: - claims; generic drugs: 1,349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandra Hlavac $2,913 ($2,913 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $1,023.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 53 | $1,023 |
| Madrigal Pharmaceuticals MDGL | 12 | $607 |
| Genzyme Corporation SNY | 10 | $284 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $194 |
| Ardelyx, Inc. ARDX | 9 | $157 |
| Inspire Medical Systems, Inc. INSP | 1 | $119 |
| Pfizer Inc. PFE | 4 | $88.8 |
| GlaxoSmithKline, LLC. GSK | 3 | $76.54 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $61.64 |
| Vivus LLC | 3 | $61.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.